SRB Corp’s CVS Health CVS Stock Holding History

SRB Corp’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.3M	Sell	506,016 -20,839	-4%	-$1.61M	2.23%	16
2025 Q4	$41.8M	Hold	526,855	–	–	2.3%	16
2025 Q3	$39.7M	Sell	526,855 -69,338	-12%	-$4.75M	2.28%	17
2025 Q2	$41.1M	Sell	596,193 -82,795	-12%	-$5.43M	2.47%	16
2025 Q1	$46M	Sell	678,988 -452,658	-40%	-$27.1M	3%	15
2024 Q4	$50.8M	Hold	1,131,646	–	–	2.91%	15
2024 Q3	$71.2M	Hold	1,131,646	–	–	3.99%	12
2024 Q2	$66.8M	Hold	1,131,646	–	–	3.96%	10
2024 Q1	$90.3M	Sell	1,131,646 -67,393	-6%	-$5.15M	5%	7
2023 Q4	$94.7M	Sell	1,199,039 -1,078,454	-47%	-$76.8M	5.59%	5
2023 Q3	$159M	Buy	2,277,493 +12,154	+0.5%	+$861K	9.63%	3
2023 Q2	$157M	Buy	2,265,339 +130,919	+6%	+$9.32M	9.19%	3
2023 Q1	$159M	Buy	2,134,420 +4,138	+0.2%	+$347K	9.98%	3
2022 Q4	$199M	Sell	2,130,282 -4,078	-0.2%	-$393K	12.59%	3
2022 Q3	$204M	Sell	2,134,360 -11,723	-0.5%	-$1.16M	14.2%	2
2022 Q2	$199M	Buy	2,146,083 +15,801	+0.7%	+$1.54M	12.89%	2
2022 Q1	$216M	Hold	2,130,282	–	–	11.99%	2
2021 Q4	$220M	Hold	2,130,282	–	–	11.47%	2
2021 Q3	$181M	Hold	2,130,282	–	–	10.88%	2
2021 Q2	$178M	Hold	2,130,282	–	–	11.53%	2
2021 Q1	$160M	Hold	2,130,282	–	–	10.94%	2
2020 Q4	$145M	Buy	2,130,282 +67,800	+3%	+$4.41M	10.71%	5
2020 Q3	$120M	Hold	2,062,482	–	–	10.08%	4
2020 Q2	$134M	Hold	2,062,482	–	–	10.96%	4
2020 Q1	$122M	Hold	2,062,482	–	–	11.39%	5
2019 Q4	$153M	Hold	2,062,482	–	–	12.38%	4
2019 Q3	$130M	Buy	2,062,482 +525,500	+34%	+$31.1M	11.43%	5
2019 Q2	$83.8M	Sell	1,536,982 -47,000	-3%	-$2.53M	7.81%	6
2019 Q1	$85.4M	Buy	1,583,982 +407,540	+35%	+$25.2M	8.04%	6
2018 Q4	$77.1M	Hold	1,176,442	–	–	8.17%	6
2018 Q3	$92.6M	Buy	1,176,442 +254,145	+28%	+$18.2M	9.22%	6
2018 Q2	$59.4M	Buy	922,297 +676,388	+275%	+$44.6M	6.51%	6
2018 Q1	$15.3M	Buy	245,909 +243,182	+8,918%	+$17.4M	1.93%	7
2017 Q4	$198K	Buy	2,727 +453	+20%	+$32.9K	0.03%	115
2017 Q3	$185K	Sell	2,274 -85	-4%	-$6.72K	0.02%	98
2017 Q2	$190K	Buy	2,359 +106	+5%	+$8.37K	0.03%	73
2017 Q1	$177K	Sell	2,253 -73	-3%	-$5.83K	0.03%	99
2016 Q4	$184K	Buy	2,326 +712	+44%	+$57.6K	0.03%	32
2016 Q3	$144K	Buy	1,614 +188	+13%	+$17.7K	0.02%	157
2016 Q2	$137K	Hold	1,426	–	–	0.02%	130
2016 Q1	$148K	Buy	+1,426	New	+$139K	0.02%	102
2014 Q4	–	Sell	-1,764	Closed	-$140K	–	188
2014 Q3	$140K	Buy	+1,764	New	+$139K	0.02%	68

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SRB Corp's CVS Position: Q1 2026 in Review

SRB Corp reduced its CVS Health (CVS) stake by 4% in Q1 2026, selling an estimated $1.61M and leaving 506,016 shares worth $36.3M. The position accounts for 2.23% of the portfolio, ranked #16.

SRB Corp first reported a position in CVS in Q3 2014 and has held it in 42 quarters since. The position peaked at $220M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

SRB Corp held 506,016 shares of CVS Health worth $36.3M as of Q1 2026.
SRB Corp sold 20,839 CVS Health shares in Q1 2026, an estimated $1.61M.
CVS Health made up 2.23% of SRB Corp's portfolio in Q1 2026, its #16 holding.
SRB Corp first reported a position in CVS Health in Q3 2014 and has held it in 42 quarters since.
SRB Corp's CVS Health position peaked at $220M in Q4 2021.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on SRB Corp's 13F filing for Q1 2026, filed 14 May 2026.